Alto Neuroscience, Inc. Common Stock (ANRO)
R&D Expenses
$64.92M
TTM · Period ending: · USD
ANRO R&D Expenses
Latest reported$64.92Mperiod ending
Latest reported$64.92Mperiod ending
ANRO TTM R&D Expenses ($26.97M → $64.92M)
TTM R&D Expenses
High-resolution chart · PNG
ANRO r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 64,923,000 | |
| 55,939,000 | |
| 45,619,000 | |
| 44,423,000 | |
| 46,958,000 | |
| 47,018,000 | |
| 46,996,000 | |
| 45,839,000 | |
| 40,746,000 | |
| 34,634,000 | |
| 30,291,000 | |
| 26,972,000 |